Extramedullary B Lymphoblastic Crisis of CML, Presenting as a Leptomeningeal Tumor - A Case Report -
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We report here on a rare case of a patient who presented with an extramedullary B lymphoblastic crisis as an initial manifestation of chronic myelogenous leukemia (CML). A 71-year-old man visited the emergency room due to suddenly developed dysarthria and right side weakness. Emergency craniotomy was done under the presumptive diagnosis of subdural hemorrhage. During the operation, a poorly demarcated firm mass was identified in the leptomeningeal space. Microscopically, the majority of the tumor was composed of monotonous immature cells with blast morphology, and these cells were immunoreactive for TdT, CD34, CD10 and CD20, indicating the precursor B-cell phenotype. The peripheral area of the tumor consisted of myeloid cells in various stages of maturation, and these cells were reactive for myeloperoxidase, chloroacetate esterase, CD43 and CD15. FISH analysis using the LSI bcr-abl dual color probe showed gene fusion signals in both the B-lymphoblasts and myeloid cells. The peripheral blood and bone marrow findings were consistent with CML with no evidence of a blast crisis. Cytogenetic study of the bone marrow demonstrated the 46, XY, t(9;22)(q34;q11) chromosome. A diagnosis of extramedullary B lymphoblastic blast crisis in a patient with Philadelphia chromosome-positive CML was made. Despite treatment, the patient died 3 months after he was diagnosed.
Abstract
We report here on a rare case of a patient who presented with an extramedullary B lymphoblastic crisis as an initial manifestation of chronic myelogenous leukemia (CML). A 71-year-old man visited the emergency room due to suddenly developed dysarthria and right side weakness. Emergency craniotomy was done under the presumptive diagnosis of subdural hemorrhage. During the operation, a poorly demarcated firm mass was identified in the leptomeningeal space. Microscopically, the majority of the tumor was composed of monotonous immature cells with blast morphology, and these cells were immunoreactive for TdT, CD34, CD10 and CD20, indicating the precursor B-cell phenotype. The peripheral area of the tumor consisted of myeloid cells in various stages of maturation, and these cells were reactive for myeloperoxidase, chloroacetate esterase, CD43 and CD15. FISH analysis using the LSI bcr-abl dual color probe showed gene fusion signals in both the B-lymphoblasts and myeloid cells. The peripheral blood and bone marrow findings were consistent with CML with no evidence of a blast crisis. Cytogenetic study of the bone marrow demonstrated the 46, XY, t(9;22)(q34;q11) chromosome. A diagnosis of extramedullary B lymphoblastic blast crisis in a patient with Philadelphia chromosome-positive CML was made. Despite treatment, the patient died 3 months after he was diagnosed.
참고문헌 (12)
- Eric D, "Hematopathology-A volume in foundations in diagnostic pathology series", pp.455~468 (2006), Philadelphia Churchill Livingstone
- Vardiman JW PR, "Chronic myelogenous leukemia. in: World Health Organization classification of tumours pathology and genetics of tumours of the haematopoietic and lymphoid tissues", pp.20~26 (2002), IARC Press
- Ichinohasama R, "Ph-negative non-Hodgkin’s lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature", Leukemia, 14, pp.169~182 (2000)
- Yashima-Abo A, "Distinguishing between proliferating nodal lymphoid blasts in chronic myelogenous leukemia and non-Hodgkin lymphoma: report of three cases and detection of a bcr", abl fusion signal by single-cell analysis, 2005, pp.55, 273~279
- Sun T, "Extramedullary blast crisis in chronic myelogenous leukemia. Demonstration of T-cell lineage and Philadelphia chromosome in a paraspinal tumor", Cancer, 68, pp.605~610 (1991)
- Ganessan K, "Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child", Pediatr Hematol Oncol, 24, pp.195~198 (2007)
- Altintas A, "Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report", J Neurooncol, 84, pp.103~105 (2007)
- Rajappa S, "Isolated central nervous system blast crisis in chronic myeloid leukemia", Hematol Oncol, 22, pp.179~181 (2004)
- Rytting ME, "Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy", Leuk Lymphoma, 45, pp.1623~1626 (2004)
- Johansson B, "Cytogenetic and molecular genetic evolution of chronic myeloid leukemia", Acta Haematol, 107, pp.76~94 (2002)
- Calabretta B, "The biology of CML blast crisis", Blood, 103, pp.4010~4022 (2004)
- Trotta R, "BCR", ABL activates mdm2 mRNA translation via the La antigen, 2003, pp.3, 145~160